Loading viewer...
conference
Format: PDF conference
Immunovant presented at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024, showcasing its pipeline of targeted therapies for autoimmune diseases. The presentation discusses the development of batoclimab and IMVT-1402, highlighting their potential as first-in-class or best-in-class candidates across multiple autoimmune indications.
conference
12 Pages
Indiana Family and Social Services Administration (FSSA)
William Demant Holding Management Presentation 2018 EUHA
conferenceconference
58 Pages
William Demant Holding
National Fuel Gas Company 2016 EnerCom Oil & Gas Conference
conferenceconference
28 Pages
National Fuel Gas Company
Manitowoc Company 2017 JP Morgan High Yield Conference
conferenceconference
20 Pages
The Manitowoc Company, Inc.